The Mepolizumab Pregnancy Exposure Study: a VAMPSS post marketing surveillance study of Mepolizumab safety in pregnancy (200870 NPSS (Nucala Pregnancy Surveillance Study))

13/06/2016
09/08/2024
EU PAS number:
EUPAS13772
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk-200870-protocol-redact

English (1.18 MB - PDF) View document
Updated protocol

gsk-200870-protocol-redact-v02

First published: 22/02/2024
English (6.95 MB - PDF) View document
Study results
Study report
Study report

Clinical Study Report Anonymized 29 Jul 2024.pdf

English (3.79 MB - PDF) View document
Other information